Pandemic led to profound changes in multiple sclerosis clinical practice
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
New School of Medicine Education Building receives full approval from UC Regents
The Regents of the University of California have given final approval for the construction of the School of Medicine’s new Education Building II at UC Riverside. The vote, which approved the final design, the full budget, and the California Environmental Quality Act, or CEQA, findings, took place during the Regents’...
How the South African COVID-19 variant was found
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
What UC Riverside scientists have to say about vaccines, variants, and antibodies
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
Experts weigh in on whether COVID-19 is here to stay
C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...
Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early
Should we be double masking?
UC Riverside epidemiologist answers this and other questions in Q&A
Biomedical scientist explains how Covid-19 vaccines work
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
Are people living with HIV more isolated during the pandemic?
A UC Riverside-led study, funded by Merck, is set to find out
School of Medicine to serve as lead site for clinical trial on stuttering
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
UC Riverside joins campuses to pilot a smartphone app that aims to limit spread of COVID-19
A program to test a smartphone-based COVID-19 exposure notification system will expand to an additional five University of California campus locations, including UC Riverside, as a result of success from an initial deployment earlier this fall at two UC campuses. The program is a joint effort between the UCs and...